WASHINGTON, Oct 19 (Reuters) - Novartis AG's (NOVN.VX: Quote, Profile, Research) (NVS.N: Quote, Profile, Research) cancer drug Gleevec will come with a new precaution about the occasional occurrence of severe congestive heart failure, U.S. health officials said on Thursday.
